New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

FOR IMMEDIATE RELEASE New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation Presentations showcased at World Transplant Congress in

Continue Reading

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated Perfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated Perfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

FOR IMMEDIATE RELEASE Analysis at ACS 2024 Highlights Benefits of Hypothermic Oxygenated Perfusion in Liver Transplantation San Francisco, California – October 21, 2024 – A compelling analysis involving 100 liver transplant cases

Continue Reading